Electronic Code of Federal Regulations
We invite you to try out our new beta eCFR site at
https://ecfr.federalregister.gov. We have made big
changes to make the eCFR easier to use. Be sure to leave feedback using the Feedback button on the bottom
right of each page!
|
e-CFR data is current as of February 24, 2021 |
Title 21 → Chapter I → Subchapter E → Part 556 → Subpart B → §556.346 |
Title 21: Food and Drugs
PART 556—TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD
Subpart B—Specific Tolerances for Residues of Approved and Conditionally Approved New Animal Drugs
§556.346 Laidlomycin.
(a) Acceptable daily intake (ADI). The ADI for total residue of laidlomycin is 7.5 µg/kg of body weight per day.
(b) Tolerances. The tolerance for laidlomycin (marker residue) is:
(1) Cattle. Liver (target tissue): 0.2 ppm.
(2) [Reserved]
(c) Related conditions of use. See §558.305 of this chapter.